0001209191-15-050164.txt : 20150604 0001209191-15-050164.hdr.sgml : 20150604 20150604171345 ACCESSION NUMBER: 0001209191-15-050164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150602 FILED AS OF DATE: 20150604 DATE AS OF CHANGE: 20150604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Modi Rajiv I. CENTRAL INDEX KEY: 0001461241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 15913684 MAIL ADDRESS: STREET 1: SARKHEJ-DHOLKA ROAD CITY: BHAT, AHMEDABAD STATE: K7 ZIP: 382 210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-02 0 0001000694 NOVAVAX INC NVAX 0001461241 Modi Rajiv I. C/O CADILA PHARMACEUTICALS LTD, CADILA CORPORATE CAMPUS, SARKHEJ- DHOLKA ROAD BHAT, AHMEDABAD GUJARAT K7 382 210 INDIA 1 0 0 0 Common Stock 2015-06-02 4 S 0 84092 8.90 D 3915908 I See footnote Common Stock 2015-06-03 4 S 0 355000 8.92 D 3560908 I See footnote Common Stock 2015-06-04 4 S 0 65589 8.92 D 3495319 I See footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares are owned directly by Satellite Overseas (Holdings) Limited, which is a wholly owned subsidiary (except for directors' qualifying shares) of Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals Ltd is an indirect beneficial owner of the reported securities. These shares are held for convenience in the name of "SOHL, Inc., as nominee for Satellite Overseas (Holdings) Limited." SOHL, Inc., has no voting, dispositive or pecuniary interest in any such shares. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ Rajiv I. Modi 2015-06-04